Alessandro D Santin

Molecular determinants of clinical outcomes of pembrolizumab in recurrent ovarian cancer: Exploratory analysis of KEYNOTE-100.

P. Jelinic, R. Cristescu, G. Sonke, 2023, Gynecologic Oncology.